URETHRAL NEOPLASM

URETHRAL NEOPLASM was reported 44 times

URETHRAL NEOPLASM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Somatostatin Analog [EPC] 2 0.0003
1 Programmed Death Ligand-1 Blocker [EPC] 1 0.0000
2 Erythropoiesis-stimulating Agent [EPC] 2 0.0000
3 Nucleoside Analog Antiviral [EPC] 2 0.0000
4 Central Nervous System Stimulant [EPC] 2 0.0000
5 Interferon beta [EPC] 3 0.0000
6 Cardiac Glycoside [EPC] 1 0.0000
7 Calcium [EPC] 2 0.0000
8 Aldosterone Antagonist [EPC] 2 0.0000
9 Arteriolar Vasodilator [EPC] 1 0.0000
10 Anti-IgE [EPC] 1 0.0000
11 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
12 Aminosalicylate [EPC] 1 0.0000
13 5-alpha Reductase Inhibitor [EPC] 1 0.0000
14 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
15 Parathyroid Hormone Analog [EPC] 1 0.0000
16 Loop Diuretic [EPC] 4 0.0000
17 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
18 alpha-Adrenergic Blocker [EPC] 1 0.0000
19 beta-Adrenergic Blocker [EPC] 2 0.0000
20 Azole Antifungal [EPC] 1 0.0000
21 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
22 Endothelin Receptor Antagonist [EPC] 1 0.0000
23 Thiazide Diuretic [EPC] 1 0.0000
24 Anti-epileptic Agent [EPC] 1 0.0000
25 Insulin Analog [EPC] 2 0.0000
26 Tumor Necrosis Factor Blocker [EPC] 4 0.0000
27 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
28 Factor Xa Inhibitor [EPC] 1 0.0000
29 Platelet Aggregation Inhibitor [EPC] 2 0.0000
30 Proton Pump Inhibitor [EPC] 2 0.0000
31 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
32 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
33 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
34 Corticosteroid [EPC] 2 0.0000